Suppr超能文献

塑造成瘾易感性——行为、神经回路和分子机制的贡献。

Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.

机构信息

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, 10029 New York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 10029 New York, NY, USA.

School of Pharmacy, Pharmacology Unit, University of Camerino, 62032 Camerino, Italy.

出版信息

Neurosci Biobehav Rev. 2018 Feb;85:117-125. doi: 10.1016/j.neubiorev.2017.05.019. Epub 2017 May 29.

Abstract

Substance use disorders continue to impose increasing medical, financial and emotional burdens on society in the form of morbidity and overdose, family disintegration, loss of employment and crime, while advances in prevention and treatment options remain limited. Importantly, not all individuals exposed to abused substances effectively develop the disease. Genetic factors play a significant role in determining addiction vulnerability and interactions between innate predisposition, environmental factors and personal experiences are also critical. Thus, understanding individual differences that contribute to the initiation of substance use as well as on long-term maladaptations driving compulsive drug use and relapse propensity is of critical importance to reduce this devastating disorder. In this paper, we discuss current topics in the field of addiction regarding individual vulnerability related to behavioral endophenotypes, neural circuits, as well as genetics and epigenetic mechanisms. Expanded knowledge of these factors is of importance to improve and personalize prevention and treatment interventions in the future.

摘要

物质使用障碍继续以发病率和过量用药、家庭破裂、失业和犯罪的形式给社会带来越来越大的医疗、经济和情感负担,而预防和治疗选择的进展仍然有限。重要的是,并非所有接触滥用物质的人都能有效地患上这种疾病。遗传因素在确定成瘾易感性方面起着重要作用,先天倾向、环境因素和个人经历之间的相互作用也至关重要。因此,了解导致物质使用开始以及长期适应不良导致强迫性药物使用和复发倾向的个体差异对于减少这种毁灭性疾病至关重要。在本文中,我们讨论了成瘾领域中与行为表型、神经回路以及遗传和表观遗传机制相关的个体易感性的当前主题。这些因素的知识扩展对于改善和个性化未来的预防和治疗干预措施很重要。

相似文献

1
Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.
Neurosci Biobehav Rev. 2018 Feb;85:117-125. doi: 10.1016/j.neubiorev.2017.05.019. Epub 2017 May 29.
2
Neuroscience of resilience and vulnerability for addiction medicine: From genes to behavior.
Prog Brain Res. 2016;223:3-18. doi: 10.1016/bs.pbr.2015.09.004. Epub 2015 Nov 23.
3
Epigenetics of drug abuse: predisposition or response.
Pharmacogenomics. 2012 Jul;13(10):1149-60. doi: 10.2217/pgs.12.94.
4
Drugs of abuse: epigenetic mechanisms in toxicity and addiction.
Curr Med Chem. 2011;18(12):1765-74. doi: 10.2174/092986711795496836.
5
In search of predictive endophenotypes in addiction: insights from preclinical research.
Genes Brain Behav. 2016 Jan;15(1):74-88. doi: 10.1111/gbb.12265. Epub 2015 Nov 13.
6
Drugs and addiction: an introduction to epigenetics.
Addiction. 2011 Mar;106(3):480-9. doi: 10.1111/j.1360-0443.2010.03321.x.
7
Epigenetic regulation in substance use disorders.
Curr Psychiatry Rep. 2010 Apr;12(2):145-53. doi: 10.1007/s11920-010-0099-5.
8
Neuroepigenetics and addictive behaviors: Where do we stand?
Neurosci Biobehav Rev. 2019 Nov;106:58-72. doi: 10.1016/j.neubiorev.2018.08.018. Epub 2018 Sep 8.
9
The epigenetic landscape of addiction.
Ann N Y Acad Sci. 2011 Jan;1216:99-113. doi: 10.1111/j.1749-6632.2010.05893.x.
10
The genetic basis of addictive disorders.
Psychiatr Clin North Am. 2012 Jun;35(2):495-519. doi: 10.1016/j.psc.2012.03.010.

引用本文的文献

2
The mesocorticolimbic system in stimulant use disorder.
Mol Psychiatry. 2025 Sep 10. doi: 10.1038/s41380-025-03148-0.
3
Decreased voluntary alcohol intake and ventral striatal epigenetic and transcriptional remodeling in male Acss2 KO mice.
Neuropharmacology. 2025 Mar 1;265:110258. doi: 10.1016/j.neuropharm.2024.110258. Epub 2024 Dec 9.
6
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.
Biology (Basel). 2024 Sep 3;13(9):690. doi: 10.3390/biology13090690.
9
tRNA epitranscriptomic alterations associated with opioid-induced reward-seeking and long-term opioid withdrawal in male mice.
Neuropsychopharmacology. 2024 Jul;49(8):1276-1284. doi: 10.1038/s41386-024-01813-6. Epub 2024 Feb 8.
10
Neuron Navigator 1 (Nav1) regulates the response to cocaine in mice.
Commun Biol. 2023 Oct 18;6(1):1053. doi: 10.1038/s42003-023-05430-9.

本文引用的文献

1
Striatal H3K27 Acetylation Linked to Glutamatergic Gene Dysregulation in Human Heroin Abusers Holds Promise as Therapeutic Target.
Biol Psychiatry. 2017 Apr 1;81(7):585-594. doi: 10.1016/j.biopsych.2016.09.015. Epub 2016 Sep 28.
2
Progress With Nonhuman Animal Models of Addiction.
J Stud Alcohol Drugs. 2016 Sep;77(5):696-9. doi: 10.15288/jsad.2016.77.696.
3
Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
Adv Pharmacol. 2016;76:67-84. doi: 10.1016/bs.apha.2016.01.002. Epub 2016 Mar 2.
5
In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward.
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2726-31. doi: 10.1073/pnas.1521238113. Epub 2016 Feb 1.
6
In search of predictive endophenotypes in addiction: insights from preclinical research.
Genes Brain Behav. 2016 Jan;15(1):74-88. doi: 10.1111/gbb.12265. Epub 2015 Nov 13.
7
Influence of the Novelty-Seeking Endophenotype on the Rewarding Effects of Psychostimulant Drugs in Animal Models.
Curr Neuropharmacol. 2016;14(1):87-100. doi: 10.2174/1570159x13666150921112841.
8
The Brain on Drugs: From Reward to Addiction.
Cell. 2015 Aug 13;162(4):712-25. doi: 10.1016/j.cell.2015.07.046.
9
Circuitry of self-control and its role in reducing addiction.
Trends Cogn Sci. 2015 Aug;19(8):439-44. doi: 10.1016/j.tics.2015.06.007.
10
Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology.
Neuropsychopharmacology. 2016 Feb;41(3):869-76. doi: 10.1038/npp.2015.213. Epub 2015 Jul 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验